PHGE
AMEXBiomX Inc.
Price$0.48-4.52 (-90.46%)
2026-03-182026-06-22
News · 26 weeks66+86%
2025-12-282026-06-21
Mix3790d
- SEC Filings19(51%)
- Other13(35%)
- Leadership3(8%)
- M&A2(5%)
Latest news
25 items- SECSEC Form DEFA14A filed by BiomX Inc.DEFA14A - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX Provides Update on Defense Technology Portfolio and Growth StrategyNETANYA, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE), a company that develops and acquires technologies for defense, security, and first-response markets, today announced that it has posted an updated informational presentation to the Company's website as part of its completed strategic transition towards the defense sector. The presentation provides an overview of BiomX's portfolio, operating framework, leadership and advisory team, and growth strategy. BiomX's current strategy is built around the growing need for technologies that can identify, analyze, and support faster responses to physical threats across high-consequence settings. The Company's portfolio current
- SECAmendment: SEC Form SCHEDULE 13D/A filed by BiomX Inc.SCHEDULE 13D/A - BiomX Inc. (0001739174) (Subject)
- SECSEC Form 424B5 filed by BiomX Inc.424B5 - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX Announces NYSE American Acceptance of Plan to Regain ComplianceNETANYA, Israel, June 12, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company") today announced that the Company's previously-submitted plan (the "Plan") to regain compliance with NYSE American LLC's listing standards was accepted, including plan compliance period through September 25, 2027. As previously reported, on March 25, 2026, the Company received written notice from NYSE American that it was not in compliance with Sections 1003(a)(i), (ii), and (iii) of the NYSE American Company Guide, which require a listed company to maintain specified levels of stockholders' equity. The notice was based on the Company's reported stockholders' deficit of $(1.302 million) as
- SECAmendment: BiomX Inc. filed SEC Form 8-K: Financial Statements and Exhibits8-K/A - BiomX Inc. (0001739174) (Filer)
- PRBiomX: Zorronet's AI Security Experts Provide In-Depth Review on Why Security AI Must Move Beyond Detection to Understanding in High-Stakes Global EventsNETANYA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a company focused on defense, security, and critical infrastructure technologies, today announced the publication of a new review by Idan Wasserman, Chief Executive Officer of Zorronet Ltd., a BiomX company, titled "The Security Industry Has Mistaken Seeing More With Being Safer." In the review, Wasserman argues that the next phase of AI-enabled security will not be defined simply by how many cameras, sensors, drones, or alerts a system can produce. Instead, he writes that the most important systems will be those that can transform information into true understanding, and that understandi
- SECSEC Form DEF 14A filed by BiomX Inc.DEF 14A - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRAnother Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at ElbitNETANYA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), today announced the appointment of Prof. Gabby Sarusi as Strategic Advisor to the Company. Prof. Sarusi will advise BiomX as the Company as the company expands its presence in the defense, security, critical infrastructure, and first-response sectors, and drawing on his experience spanning technology development, operational leadership, and long-term strategic planning. His advisory role is expected to support management in evaluating new opportunities and advancing the Company's long-term growth strategy. Prof. Sarusi brings a combination of scientific, defense-industry, commercial, and
- PRZorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud DependenceNETANYA, Israel, June 01, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), today announced the expansion of its Zorronet subsidiary's autonomous C5ISR suite to support fully secure on-premise, hybrid, and closed-loop deployments for defense, security, and critical infrastructure. The expanded offering enables organizations to run the full Zorronet C5ISR suite inside hardened sites, secured intranets, and restricted infrastructure without relying on the public cloud. The expansion reflects growing demand for autonomous command-and-control systems that can function locally inside secured infrastructure, a priority highlighted by US President Donald Trump's push to
- SECAmendment: SEC Form SCHEDULE 13D/A filed by BiomX Inc.SCHEDULE 13D/A - BiomX Inc. (0001739174) (Subject)
- SECBiomX Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRBiomX Appoints IDF Colonel (res.) Roy Timor-Rousso as Chief Business Officer to Strengthen Defense & Security OperationsNETANYA, Israel, May 27, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), today announced the appointment of Roy Timor-Rousso as Chief Business Officer (CBO), adding senior business & operational leadership as the Company continues building around defense, security, and first response technologies. As a Colonel (res.) in the Israel Defense Forces, Mr. Timor-Rousso's military leadership experience gives him direct understanding of operational command, field coordination, and how technology must serve soldiers and operators on the ground. Bringing on Mr. Timor-Rousso further strengthens BiomX's operating structure with leadership experience in coordinating subsid
- SECSEC Form 10-Q filed by BiomX Inc.10-Q - BiomX Inc. (0001739174) (Filer)
- SECSEC Form NT 10-Q filed by BiomX Inc.NT 10-Q - BiomX Inc. (0001739174) (Filer)
- PRBiomX's Zorronet Puts Full AI Command-and-Control in the Palm of Your HandNETANYA, Israel, May 06, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company") today announced that its Zorronet subsidiary has launched a secure mobile application that brings its system directly to operators in the field, available now on Google Play and the Apple App Store, and is available for all customers. Zorronet develops AI-powered software that connects cameras, sensors, drones, and IoT devices into a single system. Its technology is already in use in cities and regional councils and across Israel, as well as with Israel Railways, among other organizations. Today, control room operators deal with more data than they can realistically process. Alerts come fr
- SECBiomX Inc. filed SEC Form 8-K: Other Events8-K - BiomX Inc. (0001739174) (Filer)
- SECAmendment: SEC Form 10-K/A filed by BiomX Inc.10-K/A - BiomX Inc. (0001739174) (Filer)
- SECBiomX Inc. filed SEC Form 8-K: Other Events, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
- PRZorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection SystemsNETANYA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company") today highlighted the successful deployment of its Zorronet subsidiary in collaboration with Israel Railways, focused on protecting wildlife and safeguarding national infrastructure. Over the past year, a large-scale pilot project, with an investment by Israel Railways of approximately NIS 800,000, was completed and declared a success. The project achieved a success rate of 98% at keeping large animals - including wild boar, foxes, and gazelles - off of railway tracks in the sections it was deployed in. These animals would otherwise have wandered onto the tracks, thereby preserving ecolog
- SECAmendment: SEC Form SCHEDULE 13D/A filed by BiomX Inc.SCHEDULE 13D/A - BiomX Inc. (0001739174) (Subject)
- SECBiomX Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - BiomX Inc. (0001739174) (Filer)
PHGE FAQ
7 questionsWhat does BiomX Inc. do?
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). The company's lead product candidate BX001, which is in Phase II that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type. Its products under...Where does PHGE stock trade?
BiomX Inc. (PHGE) is listed on AMEX.What sector and industry is PHGE in?
BiomX Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did BiomX Inc. go public?
BiomX Inc. (PHGE) completed its IPO in 2019.What are analysts saying about PHGE?
BiomX Inc. has had 3 recent analyst actions on file. The most recent action was from Chardan Capital: Buy with a $1300.00 price target on 2021-11-16. Recent price targets range from $1000.00 to $1600.00.What companies are similar to PHGE?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare PHGE side-by-side with any of them on Quantisnow.How can I track PHGE on Quantisnow?
Quantisnow aggregates BiomX Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PHGE to receive live email and push alerts on every new disclosure.